Data-Driven Decision Making

Guggenheim Investments' new $250M vehicle, backed by LGT Capital Partners, highlights the strategic depth and enduring allure of the private credit market.

As ENvue Medical prepares to ring the Nasdaq bell, a look at how its non-invasive tech for tube placement and pain relief is shaking up the MedTech world.

The strategic merger creates a new powerhouse in financial data, aiming to challenge giants with a new AI-driven platform, Vanda Analytics.

As John Partilla steps down after a decade, Jeff Howe takes the helm to guide Screenvision through a pivotal era for cinema advertising and innovation.

With survey fraud costing millions, Rep Data appoints a former Kantar CIO and Research Defender's founder to sharpen its tech and product focus.

A new partnership introduces Utilix, an intelligent software aiming to transform static displays into dynamic, data-driven experiences for retail and beyond.

A new partnership arms independent cancer clinics with advanced AI and data analytics, aiming to improve patient care and ensure their survival.

NeuroSense adds world-renowned expert Prof. Steven Arnold to its board, a major vote of confidence in its multi-target Alzheimer's drug, PrimeC.

A new partnership aims to bring cutting-edge cancer trials to community clinics, accelerating drug development and expanding patient access to care.

With record growth and a fortified cash position, ElevateBio combines AI-driven discovery and industrial-scale manufacturing to power the gene therapy boom.

Challenger brand Kodiak partners with analytics giant NIQ, signaling a new data-driven era for competition in the crowded CPG breakfast and snacking aisles.

CEO Werner Lanthaler will present FairJourney Bio's data-driven antibody discovery platform at the elite J.P. Morgan conference, signaling major growth.

After success in Europe, Allotex gets FDA nod to begin U.S. trials for its tissue-based presbyopia treatment, offering new hope for millions.

South Korean gim specialist Daingt is leveraging proprietary data and a 20-year legacy to innovate its seaweed, aiming to dominate the booming global market.

Fox News shattered records in 2025 with 4.5B YouTube views, dominating rivals and signaling a strategic shift from cable supremacy to online dominance.

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.

Health tech firm IMVARIA, maker of an FDA-authorized AI for lung disease, has secured strategic funding from InHealth Ventures and Labcorp to expand its reach.

The MTA's major investment in Wabtec's hybrid locomotives promises cleaner air for New York, safer work for crews, and a more reliable subway system.

LUMA Vision's VERAFEYE™ system combines AI with real-time 4D heart visualization, promising to make complex AFib procedures faster, safer, and more precise.

With star hires and proprietary data analytics, Abacus Global Management is making an ambitious play for the booming asset-based finance sector.